Literature DB >> 11772480

Detecting smoking following smoking cessation treatment.

Peter Gariti1, Arthur I Alterman, Ronald Ehrman, Francis D Mulvaney, Charles P O'Brien.   

Abstract

Our study compared the results of self-report (SR) plus breath carbon monoxide (CO) monitoring to SR plus urine cotinine (COT) analysis of recent tobacco use for a recently completed smoking cessation study that compared the efficacy of different intensities of psychosocial treatments coupled with 8 weeks of patch treatment. Treatment outcomes were assessed 9, 26, and 52 weeks from treatment initiation in 200+ patients using both measurement types. COT was able to detect self-reported smoking in over 97% of the cases at all time points, while CO detected self-reported smoking 62, 84, and 89% of the time for the three follow-up assessments. Under 2% of those reporting nonsmoking were found to be smoking via CO, whereas COT found smoking to have occurred for 23, 15, and 7% of the 'nonsmoking' SRs at the three time points. Abstinence rates using SR plus CO were 49, 29, and 26%, contrasted with abstinence rates of 38, 26, and 25% for SR plus COT. These findings suggest that use of urine analysis for COT may lead to more accurate but lowered measured abstinence rates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11772480     DOI: 10.1016/s0376-8716(01)00162-4

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  12 in total

1.  Breath carbon monoxide and semiquantitative saliva cotinine as biomarkers for smoking.

Authors:  Gina F Marrone; Mane Paulpillai; Rebecca J Evans; Edward G Singleton; Stephen J Heishman
Journal:  Hum Psychopharmacol       Date:  2010-01       Impact factor: 1.672

2.  Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence.

Authors:  Kenneth A Perkins; Joshua L Karelitz; Nancy C Jao
Journal:  Nicotine Tob Res       Date:  2012-09-18       Impact factor: 4.244

3.  Sequential combination of self-report, breath carbon monoxide, and saliva cotinine to assess smoking status.

Authors:  M A Javors; J P Hatch; R J Lamb
Journal:  Drug Alcohol Depend       Date:  2010-09-06       Impact factor: 4.492

4.  D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation.

Authors:  Elizabeth J Santa Ana; Bruce J Rounsaville; Tami L Frankforter; Charla Nich; Theresa Babuscio; James Poling; Kishorchandra Gonsai; Kevin P Hill; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2009-07-09       Impact factor: 4.492

5.  Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence.

Authors:  Peter Jatlow; Benjamin A Toll; Vanessa Leary; Suchitra Krishnan-Sarin; Stephanie S O'Malley
Journal:  Drug Alcohol Depend       Date:  2008-07-22       Impact factor: 4.492

6.  Strategies of smoking cessation intervention before hernia surgery--effect on perioperative smoking behavior.

Authors:  L T Sørensen; U Hemmingsen; T Jørgensen
Journal:  Hernia       Date:  2007-05-15       Impact factor: 4.739

7.  A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India.

Authors:  Raka Jain; Sonali Jhanjee; Veena Jain; Tina Gupta; Swati Mittal; Patricia Goelz; E Paul Wileyto; Robert A Schnoll
Journal:  Nicotine Tob Res       Date:  2013-08-14       Impact factor: 4.244

8.  Brain substrates of early (4h) cigarette abstinence: Identification of treatment targets.

Authors:  Teresa R Franklin; Kanchana Jagannathan; Nathan Hager; Zhuo Fang; Sihua Xu; Joyce Wong; Anna Rose Childress; John A Detre; Hengyi Rao; Reagan Wetherill
Journal:  Drug Alcohol Depend       Date:  2017-11-20       Impact factor: 4.492

9.  Effects of smoking cessation on biological monitoring markers in urine.

Authors:  Yuya Kawasaki; Yun-Shan Li; Yuko Ootsuyama; Kazuhiko Nagata; Hiroshi Yamato; Kazuaki Kawai
Journal:  Genes Environ       Date:  2020-09-11

10.  Factors Associated with Smoking Cessation Among Quit Smart(™) Participants.

Authors:  Karen M Polizzi; Douglas W Roblin; Adrienne D Mims; Dianne Harris; Dennis D Tolsma
Journal:  Perm J       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.